Incannex Healthcare forms Clinical Advisory Board for PSX-001 anxiety program

Incannex Healthcare Inc.

Clinical Advisory Board (CAB) established to support PSX-001 development for generalized anxiety disorder.
CAB will advise on trial design, endpoint selection, regulatory engagement, and strategic approach.
Inaugural members: Dr. C. Neill Epperson, Dr. Charles B. Nemeroff, and Dr. Alan F. Schatzberg.
CMO Dr. Lou Barbato says CAB will help inform key development decisions and support shareholder value.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.